Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism (Q46763980)
Jump to navigation
Jump to search
scientific article published in November 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism |
scientific article published in November 2005 |
Statements
1 reference
Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism (English)
1 reference
Barbara E Bierer
1 reference
Jason E Foley
1 reference
Unsu Jung
1 reference
Angel Miera
1 reference
Todd Borenstein
1 reference
Jacopo Mariotti
1 reference
Michael Eckhaus
1 reference
Daniel H Fowler
1 reference
1 November 2005
1 reference
1 reference
175
1 reference
9
1 reference
5732-5743
1 reference
Identifiers
1 reference